Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Wegovy Prescribing Information, revised February 2026
While human studies have not confirmed this risk, monitoring is recommended: New lump or swelling in the neck Difficulty swallowing or breathing Persistent hoarseness People with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use semaglutide
(Clearing the System) Because tirzepatide and semaglutide both have long half-lives (5 or 7 days, respectively), healthcare providers may recommend a short washout period before starting the new medication
What's Included: 1 Multi-dose delivery system containing a stable Semaglutide solution, meticulously engineered to provide precise, low-volume introductory subcutaneous doses
Choosing reputable compounding pharmacies with proper certifications helps minimize these risks
US$ 20.36
US$ 21.27
US$ 27.96
US$ 25.96
US$ 22.64
